1 - 25 of 32 results for author:"Brynda J." in Literature citations
Results Customize
› Repeat search in UniProtKB (7)
| Synthesis, structure-activity relationship studies, and X-ray crystallographic analysis of arylsulfonamides as potent carbonic anhydrase inhibitors. Gitto R., Damiano F.M., Mader P., De Luca L., Ferro S., Supuran C.T., Vullo D., Brynda J., Rezacova P., Chimirri A. J. Med. Chem. 55:3891-3899(2012) · Mapped (1) |
| The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavir. Dostal J., Brynda J., Hruskova-Heidingsfeldova O., Pachl P., Pichova I., Rezacova P. J Enzyme Inhib Med Chem 27:160-165(2012) · Mapped (1) |
| Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni. Jilkova A., Rezacova P., Lepsik M., Horn M., Vachova J., Fanfrlik J., Brynda J., McKerrow J.H., Caffrey C.R., Mares M. J. Biol. Chem. 286:35770-35781(2011) · UniProtKB (1) |
| Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides. Mader P., Brynda J., Gitto R., Agnello S., Pachl P., Supuran C.T., Chimirri A., Rezacova P. J. Med. Chem. 54:2522-2526(2011) · Mapped (1) |
| Structure of the mouse galectin-4 N-terminal carbohydrate-recognition domain reveals the mechanism of oligosaccharide recognition. Krejcirikova V., Pachl P., Fabry M., Maly P., Rezacova P., Brynda J. Acta Crystallogr. D Biol. Crystallogr. 67:204-211(2011) · Mapped (6) |
| Structure of the human FOXO4-DBD-DNA complex at 1.9 A resolution reveals new details of FOXO binding to the DNA. Boura E., Rezabkova L., Brynda J., Obsilova V., Obsil T. Acta Crystallogr. D Biol. Crystallogr. 66:1351-1357(2010) · Mapped (1) |
| Crystal structure and functional characterization of an immunomodulatory salivary cystatin from the soft tick Ornithodoros moubata. Salat J., Paesen G.C., Rezacova P., Kotsyfakis M., Kovarova Z., Sanda M., Majtan J., Grunclova L., Horka H., Andersen J.F. et al. Biochem. J. 429:103-112(2010) · UniProtKB (1) |
| Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies. Gitto R., Agnello S., Ferro S., De Luca L., Vullo D., Brynda J., Mader P., Supuran C.T., Chimirri A. J. Med. Chem. 53:2401-2408(2010) · Mapped (7) |
| Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. Rezacova P., Pokorna J., Brynda J., Kozisek M., Cigler P., Lepsik M., Fanfrlik J., Rezac J., Grantz Saskova K., Sieglova I. et al. J. Med. Chem. 52:7132-7141(2009) · Mapped (1) |
| Structural organization of WrbA in apo- and holoprotein crystals. Wolfova J., Smatanova I.K., Brynda J., Mesters J.R., Lapkouski M., Kuty M., Natalello A., Chatterjee N., Chern S.Y., Ebbel E. et al. Biochim. Biophys. Acta 1794:1288-1298(2009) · Mapped (1) |
| Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir. Saskova K.G., Kozisek M., Rezacova P., Brynda J., Yashina T., Kagan R.M., Konvalinka J. J. Virol. 83:8810-8818(2009) · Mapped (2) |
| The crystal structure of the secreted aspartic protease 1 from Candida parapsilosis in complex with pepstatin A. Dostal J., Brynda J., Hruskova-Heidingsfeldova O., Sieglova I., Pichova I., Rezacova P. J. Struct. Biol. 167:145-152(2009) · Mapped (1) |
| Soluble recombinant CD69 receptors optimized to have an exceptional physical and chemical stability display prolonged circulation and remain intact in the blood of mice. Vanek O., Nalezkova M., Kavan D., Borovickova I., Pompach P., Novak P., Kumar V., Vannucci L., Hudecek J., Hofbauerova K. et al. FEBS J. 275:5589-5606(2008) · UniProtKB (1) |
| Crystallization and preliminary X-ray diffraction analysis of mouse galectin-4 N-terminal carbohydrate recognition domain in complex with lactose. Krejcirikova V., Fabry M., Markova V., Maly P., Rezacova P., Brynda J. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 64:665-667(2008) · Mapped (6) |
| Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir. Saskova K.G., Kozisek M., Lepsik M., Brynda J., Rezacova P., Vaclavikova J., Kagan R.M., Machala L., Konvalinka J. Protein Sci. 17:1555-1564(2008) · Mapped (1) |
| Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region. Kozisek M., Saskova K.G., Rezacova P., Brynda J., van Maarseveen N.M., De Jong D., Boucher C.A., Kagan R.M., Nijhuis M., Konvalinka J. J. Virol. 82:5869-5878(2008) · UniProtKB (1) |
| Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations. Kral V., Mader P., Collard R., Fabry M., Horejsi M., Rezacova P., Kozisek M., Zavada J., Sedlacek J., Rulisek L. et al. |
| Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants. Kozisek M., Bray J., Rezacova P., Saskova K., Brynda J., Pokorna J., Mammano F., Rulisek L., Konvalinka J. J. Mol. Biol. 374:1005-1016(2007) · Mapped (1) |
| Role of the carbohydrate recognition domains of mouse galectin-4 in oligosaccharide binding and epitope recognition and expression of galectin-4 and galectin-6 in mouse cells and tissues. Markova V., Smetana K. Jr., Jenikova G., Lachova J., Krejcirikova V., Poplstein M., Fabry M., Brynda J., Alvarez R.A., Cummings R.D. et al. Int. J. Mol. Med. 18:65-76(2006) · Mapped (8) |
| On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution. Duskova J., Dohnalek J., Skalova T., Petrokova H., Vondrackova E., Hradilek M., Konvalinka J., Soucek M., Brynda J., Fabry M. et al. Acta Crystallogr. D Biol. Crystallogr. 62:489-497(2006) · Mapped (1) |
| From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease. Cigler P., Kozisek M., Rezacova P., Brynda J., Otwinowski Z., Pokorna J., Plesek J., Gruner B., Doleckova-Maresova L., Masa M. et al. Proc. Natl. Acad. Sci. U.S.A. 102:15394-15399(2005) · Mapped (1) |
| Regular arrangement of periodates bound to lysozyme. Ondracek J., Weiss M.S., Brynda J., Fiala J., Jursik F., Rezacova P., Jenner L.B., Sedlacek J. Acta Crystallogr. D Biol. Crystallogr. 61:1181-1189(2005) · Mapped (1) |
| Crystal structure of a cross-reaction complex between an anti-HIV-1 protease antibody and an HIV-2 protease peptide. Rezacova P., Brynda J., Lescar J., Fabry M., Horejsi M., Sieglova I., Sedlacek J., Bentley G.A. J. Struct. Biol. 149:332-337(2005) · Mapped (1) |
| Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant. Zakova L., Brynda J., Au-Alvarez O., Dodson E.J., Dodson G.G., Whittingham J.L., Brzozowski A.M. Biochemistry 43:16293-16300(2004) · Mapped (1) |
| Role of hydroxyl group and R/S configuration of isostere in binding properties of HIV-1 protease inhibitors. Petrokova H., Duskova J., Dohnalek J., Skalova T., Vondrackova-Buchtelova E., Soucek M., Konvalinka J., Brynda J., Fabry M., Sedlacek J. et al. Eur. J. Biochem. 271:4451-4461(2004) · UniProtKB (1) |